Paul Matteis has joined Stifel Financial Corp. as managing director and senior analyst covering the biotechnology sector.
Matteis is based in the firm's Boston office. He will co-head Stifel's biotech team along with co-head Steve Willey, a managing director and senior analyst.
Matteis most recently was a senior biotechnology analyst covering small-cap and mid-cap companies at Leerink Partners LLC.
